| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -102,600 | 100% | $23.47 | -$2,407,513 |
| Net | -2 | -102,600 | -100% | -$2,407,513 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Walter S. Woltosz | Director, 10%+ Owner | $59,806,851 | -$2,369,434 | -3.8% | 30 Jan 2026 |
| John Anthony DiBella II | Chief Revenue Officer | $875,259 | 06 Feb 2026 | ||
| Jill Fiedler-Kelly | President, Services Solutions | $755,603 | 28 Jan 2026 | ||
| David L. Ralph | Director | $559,741 | 30 Nov 2021 | ||
| Sharlene Evans | Director | $274,470 | 30 Jan 2026 | ||
| Daniel L. Weiner | Director | $263,058 | 30 Jan 2026 | ||
| John Kenneth Paglia | Director | $227,364 | 30 Jan 2026 | ||
| Lisa LaVange | Director | $168,558 | -$38,079 | -18% | 01 Dec 2025 |
| Steven Chang | President, Immunetrics | 19 Oct 2023 | |||
| William W. Frederick | Evp/Cfo | 16 Oct 2025 | |||
| Brett Howell | Business Unit President | 19 Oct 2023 | |||
| Michael E. Raymer | Business Unit President | 11 Jun 2024 | |||
| Daniel Szot | Chief Revenue Officer | 17 Oct 2024 | |||
| Shawn Oconnor | Chief Executive Officer | 16 Oct 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John Anthony DiBella II | SLP | Common Stock | Options Exercise | 12.9% | 10,300 | 90,140 | 06 Feb 2026 | Direct | ||
| John Anthony DiBella II | SLP | Stock Options (Right to Buy) | Options Exercise | -100% | -10,300 | 0 | 06 Feb 2026 | Direct | ||
| Sharlene Evans | SLP | Common Stock | Award | 13.4% | 1,776 | 15,056 | 30 Jan 2026 | Direct | ||
| John Kenneth Paglia | SLP | Common Stock | Award | 16.6% | 1,776 | 12,472 | 30 Jan 2026 | Direct | ||
| Walter S. Woltosz | SLP | Common Stock | Award | 0.05% | 1,776 | 3,280,683 | 30 Jan 2026 | Direct | ||
| Daniel L. Weiner | SLP | Common Stock | Award | 14% | 1,776 | 14,430 | 30 Jan 2026 | Direct | ||
| Jill Fiedler-Kelly | SLP | Common Stock | Options Exercise | 13% | 8,950 | 77,817 | 28 Jan 2026 | Direct | ||
| Jill Fiedler-Kelly | SLP | Employee Stock Option (Right to Buy) | Options Exercise | -100% | -8,950 | 0 | 28 Jan 2026 | Direct | ||
| Walter S. Woltosz | SLP | Common Stock | Gift | -0.28% | -9,095 | 3,278,907 | 18 Dec 2025 | Direct | ||
| Lisa LaVange | SLP | Common Stock | Sale | -7.99% | $14,644 | $16.91 | -866 | 9,968 | 01 Dec 2025 | Direct |
| Sharlene Evans | SLP | Common Stock | Award | 15.4% | 1,771 | 13,280 | 03 Nov 2025 | Direct | ||
| Lisa LaVange | SLP | Common Stock | Award | 19.5% | 1,771 | 10,834 | 03 Nov 2025 | Direct | ||
| John Kenneth Paglia | SLP | Common Stock | Award | 19.8% | 1,771 | 10,696 | 03 Nov 2025 | Direct | ||
| Walter S. Woltosz | SLP | Common Stock | Award | 0.05% | 1,771 | 3,288,002 | 03 Nov 2025 | Direct | ||
| Daniel L. Weiner | SLP | Common Stock | Award | 16.3% | 1,771 | 12,654 | 03 Nov 2025 | Direct | ||
| Shawn Oconnor | SLP | Stock Options (Right to Buy) | Award | 50,000 | 50,000 | 16 Oct 2025 | Direct | |||
| William W. Frederick | SLP | Stock Options (Right to Buy) | Award | 32,500 | 32,500 | 16 Oct 2025 | Direct | |||
| Jill Fiedler-Kelly | SLP | Stock Options (Right to Buy) | Award | 27,500 | 27,500 | 16 Oct 2025 | Direct | |||
| John Anthony DiBella II | SLP | Stock Options (Right to Buy) | Award | 27,500 | 27,500 | 16 Oct 2025 | Direct | |||
| Walter S. Woltosz | SLP | Common Stock | Sale | -0.6% | $307,800 | $15.39 | -20,000 | 3,286,231 | 01 Oct 2025 | Direct |
| Lisa LaVange | SLP | Common Stock | Sale | -8.73% | $12,225 | $14.10 | -867 | 9,063 | 02 Sep 2025 | Direct |
| Walter S. Woltosz | SLP | Common Stock | Award | 0.06% | 2,074 | 3,306,231 | 01 Aug 2025 | Direct | ||
| Daniel L. Weiner | SLP | Common Stock | Award | 23.5% | 2,074 | 10,883 | 01 Aug 2025 | Direct | ||
| John Kenneth Paglia | SLP | Common Stock | Award | 30.3% | 2,074 | 8,925 | 01 Aug 2025 | Direct | ||
| Sharlene Evans | SLP | Common Stock | Award | 22% | 2,074 | 11,509 | 01 Aug 2025 | Direct | ||
| Lisa LaVange | SLP | Common Stock | Sale | -8.03% | $11,210 | $12.93 | -867 | 9,930 | 01 Aug 2025 | Direct |
| Lisa LaVange | SLP | Common Stock | Award | 23.8% | 2,074 | 10,797 | 01 Aug 2025 | Direct | ||
| Walter S. Woltosz | SLP | Common Stock | Sale | -0.6% | $366,623 | $18.33 | -20,000 | 3,304,157 | 01 Jul 2025 | Direct |
| Walter S. Woltosz | SLP | Common Stock | Sale | -0.6% | $543,074 | $27.15 | -20,000 | 3,324,157 | 02 Jun 2025 | Direct |
| Walter S. Woltosz | SLP | Common Stock | Sale | -0.59% | $670,150 | $33.51 | -20,000 | 3,344,157 | 01 May 2025 | Direct |
| Walter S. Woltosz | SLP | Common Stock | Award | 0.02% | 786 | 3,364,157 | 01 May 2025 | Direct | ||
| Sharlene Evans | SLP | Common Stock | Award | 9.09% | 786 | 9,435 | 01 May 2025 | Direct | ||
| Lisa LaVange | SLP | Common Stock | Award | 9.9% | 786 | 8,723 | 01 May 2025 | Direct | ||
| Daniel L. Weiner | SLP | Common Stock | Award | 9.8% | 786 | 8,809 | 01 May 2025 | Direct | ||
| John Kenneth Paglia | SLP | Common Stock | Award | 13% | 786 | 6,851 | 01 May 2025 | Direct | ||
| Walter S. Woltosz | SLP | Common Stock | Sale | -0.59% | $481,786 | $24.09 | -20,000 | 3,363,371 | 01 Apr 2025 | Direct |